AMCP Legislative & Regulatory Briefing — March 2025

House Passes 6-month Continuing Resolution, Health Care Extenders
On the evening of March 11, the House of Representatives passed a Continuing Resolution (CR), which funds the federal government at existing levels until Sept. 30.

House Holds Hearing on PBM Reform, Anti-competitiveness
Despite the removal of PBM reform provisions from last December’s government funding package, members of the House Energy & Commerce (E&C) Committee appear poised to reinvigorate the push for passage in 2025.

Tracking Actions from the Second Trump Administration
Immediately following his inauguration on Jan. 20, President Trump took to his desk to sign dozens of executive actions into law.

Senate Introduces Bipartisan PBM Reform Bill
Senators Welch (D-VT), Marshall (R-KS), Warner (D-VA), and Cassidy (R-LA) introduced the Protecting Pharmacies in Medicaid Act on March 12.

AMCP Submits Comments on the Accelerated Approval Program
On Jan. 7, the FDA and HHS released a draft guidance document regarding the accelerated approval program, as well as considerations for determining whether a confirmatory trial is “underway”.

AMCP Holds 2025 Policy Outlook Webinar
Last month, AMCP’s Adam Colborn, Associate Vice President of Government Affairs, and Geni Tunstall, Associate Vice President of Regulatory Affairs, presented an hour-long webinar titled Policy Outlook 2025: The Trump Administration and the 119th Congress.

Now Live: AMCP Podcast on Health Policy and Regulations withthe New Trump Administration
Unscripted, the AMCP Podcast offers valuable updates for listeners and connects sponsors with health care professionals, payers, policymakers, regulators, and industry leaders.

Download Full Briefing